Teva, Viatris win new chance to challenge J&J schizophrenia drug patent By Reuters
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent…
14,107€
-2,64%
Echtzeit-Aktienkurs Viatris Inc.
Bid:
Ask:
Nachrichten zur Viatris Inc. Aktie
Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
FARMINGTON HILLS, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company…
Viatris Stock Is Still Worth Buying
…
Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR of 2.82%
The Global Pregabalin Market Size was Valued at USD 1.65 Billion in 2023 and the Worldwide Pregabalin Market Size is…
Viatris Inc. (VTRS) R&D Event (Transcript)
…
Viatris Inc. (VTRS) Q4 2023 Earnings Call Transcript
…
Viatris reports upbeat 2024 revenue outlook By Investing.com
Viatris reports upbeat 2024 revenue outlook…